JP2017513829A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513829A5
JP2017513829A5 JP2016561677A JP2016561677A JP2017513829A5 JP 2017513829 A5 JP2017513829 A5 JP 2017513829A5 JP 2016561677 A JP2016561677 A JP 2016561677A JP 2016561677 A JP2016561677 A JP 2016561677A JP 2017513829 A5 JP2017513829 A5 JP 2017513829A5
Authority
JP
Japan
Prior art keywords
complex
deficiency
butyl
acyl
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016561677A
Other languages
English (en)
Japanese (ja)
Other versions
JP7082861B2 (ja
JP2017513829A (ja
JP7082861B6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/057606 external-priority patent/WO2015155231A1/en
Publication of JP2017513829A publication Critical patent/JP2017513829A/ja
Publication of JP2017513829A5 publication Critical patent/JP2017513829A5/ja
Publication of JP7082861B2 publication Critical patent/JP7082861B2/ja
Application granted granted Critical
Publication of JP7082861B6 publication Critical patent/JP7082861B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016561677A 2014-04-08 2015-04-08 新規な細胞透過性サクシネート化合物 Active JP7082861B6 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201470190 2014-04-08
DKPA201470190 2014-04-08
PCT/EP2015/057606 WO2015155231A1 (en) 2014-04-08 2015-04-08 Novel cell-permeable succinate compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020018467A Division JP7229189B2 (ja) 2014-04-08 2020-02-06 新規な細胞透過性サクシネート化合物

Publications (4)

Publication Number Publication Date
JP2017513829A JP2017513829A (ja) 2017-06-01
JP2017513829A5 true JP2017513829A5 (cg-RX-API-DMAC7.html) 2018-04-12
JP7082861B2 JP7082861B2 (ja) 2022-06-09
JP7082861B6 JP7082861B6 (ja) 2023-12-22

Family

ID=58804197

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016561677A Active JP7082861B6 (ja) 2014-04-08 2015-04-08 新規な細胞透過性サクシネート化合物
JP2020018467A Active JP7229189B2 (ja) 2014-04-08 2020-02-06 新規な細胞透過性サクシネート化合物
JP2021119813A Pending JP2021169518A (ja) 2014-04-08 2021-07-20 新規な細胞透過性サクシネート化合物
JP2021119885A Pending JP2021169519A (ja) 2014-04-08 2021-07-20 新規な細胞透過性サクシネート化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020018467A Active JP7229189B2 (ja) 2014-04-08 2020-02-06 新規な細胞透過性サクシネート化合物
JP2021119813A Pending JP2021169518A (ja) 2014-04-08 2021-07-20 新規な細胞透過性サクシネート化合物
JP2021119885A Pending JP2021169519A (ja) 2014-04-08 2021-07-20 新規な細胞透過性サクシネート化合物

Country Status (25)

Country Link
US (2) US11147789B2 (cg-RX-API-DMAC7.html)
EP (2) EP3391941B1 (cg-RX-API-DMAC7.html)
JP (4) JP7082861B6 (cg-RX-API-DMAC7.html)
KR (1) KR102322543B1 (cg-RX-API-DMAC7.html)
CN (1) CN106458957B (cg-RX-API-DMAC7.html)
AU (2) AU2015243346C9 (cg-RX-API-DMAC7.html)
CA (1) CA2944565C (cg-RX-API-DMAC7.html)
CY (1) CY1120650T1 (cg-RX-API-DMAC7.html)
DK (1) DK3129016T3 (cg-RX-API-DMAC7.html)
EA (1) EA035678B1 (cg-RX-API-DMAC7.html)
ES (2) ES2953522T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181126T1 (cg-RX-API-DMAC7.html)
IL (1) IL247904B (cg-RX-API-DMAC7.html)
LT (2) LT3129016T (cg-RX-API-DMAC7.html)
MA (2) MA44092B1 (cg-RX-API-DMAC7.html)
MX (1) MX378072B (cg-RX-API-DMAC7.html)
PL (1) PL3129016T3 (cg-RX-API-DMAC7.html)
PT (2) PT3129016T (cg-RX-API-DMAC7.html)
RS (1) RS57624B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201607907PA (cg-RX-API-DMAC7.html)
SI (1) SI3129016T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800429T1 (cg-RX-API-DMAC7.html)
TR (1) TR201810411T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015155231A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201606608B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106255509A (zh) 2014-04-08 2016-12-21 纽维制药有限公司 用于在归因于线粒体氧化磷酸化的复合体i相关损伤的乳酸性酸中毒或药物诱导的副作用的治疗中应用的琥珀酸酯前药
ES2953522T3 (es) * 2014-04-08 2023-11-14 Abliva Ab Compuestos de succinato novedosos con permeabilidad celular
KR20160143731A (ko) * 2014-04-08 2016-12-14 뉴로바이브 파마슈티컬 에이비 Atp 생산을 증가시키기 위한 숙신산 프로드러그
WO2017060422A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of mitochondrial disorders
WO2017060400A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of disesases related to mitochondrial dysfunctions
WO2017060418A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of mitochondria-related diseases
WO2017096270A1 (en) 2015-12-03 2017-06-08 The Regents Of The University Of California Methods for treating mitochondrial diseases
EP3863596A4 (en) * 2018-10-11 2022-08-10 Imbria Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LEBERIAN OPTIC ATROPHY
JP2022504584A (ja) * 2018-10-11 2022-01-13 インブリア ファーマシューティカルズ, インコーポレイテッド Tca回路中間体およびその使用方法
CN109675037B (zh) * 2019-01-25 2021-09-14 南方医科大学 Atp及其受体在制备治疗自闭症药物中的应用
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756422A (en) * 1950-09-14 1956-09-05 Saint Gobain Esters of urethanes of glycols and the manufacture thereof
NL6806584A (cg-RX-API-DMAC7.html) * 1965-09-20 1968-11-12
FR2265355B1 (cg-RX-API-DMAC7.html) 1974-03-28 1977-11-04 Blum Jean
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
DE4101158C2 (de) * 1991-01-14 1994-06-23 Dainippon Ink & Chemicals Wärmehärtbare Reaktionsharzgemische, Verwendung der erfindungsgemäßen Reaktionsharze zur Herstellung von Formkörpern und Beschichtungen
EP0583480A4 (en) 1992-02-07 1994-03-18 Tsumura & Co Side-effect alleviant.
JPH07331262A (ja) * 1994-05-31 1995-12-19 Tonen Corp パティキュレート低減用添加剤及び該添加剤を用いたディーゼルエンジン用燃料組成物
CN1222139A (zh) * 1996-06-13 1999-07-07 里奥药物制品有限公司 多元醇琥珀酸酯及其药物制剂
GB9612331D0 (en) * 1996-06-13 1996-08-14 Leo Pharm Prod Ltd Chemical compounds
WO2000001838A2 (en) 1998-07-02 2000-01-13 The Board Of Regents Of The Leland Stanford Junior University Methods for making polyketides
AUPR059400A0 (en) * 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
US7727713B2 (en) * 2001-06-20 2010-06-01 Nuevolution A/S Templated molecules and methods for using such molecules
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
KR100791844B1 (ko) 2006-06-30 2008-01-07 주식회사유한양행 메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법
KR101069502B1 (ko) 2006-10-31 2011-09-30 (주)아모레퍼시픽 비만 및 당뇨병 개선용 경구용 조성물
US20120308646A1 (en) * 2007-01-18 2012-12-06 Hesheng Zhang Tetracyclic anthraquinones possessing anti-cancer properties
JP2010522762A (ja) 2007-03-26 2010-07-08 サルトリア・フアーマシユーテイカルズ・エル・エル・シー 糖尿病の治療のための方法及びプロブコール誘導体の組成物
US8410139B2 (en) * 2009-10-07 2013-04-02 Bristol-Myers Squibb Company Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
JP2014024772A (ja) 2012-07-25 2014-02-06 Univ Of Tokyo ミトコンドリアのatp産生能昂進剤
ES2661009T3 (es) 2012-10-05 2018-03-27 Neurovive Pharmaceutical Ab Succinatos protegidos para mejorar la producción de ATP mitocondrial
CN106255509A (zh) 2014-04-08 2016-12-21 纽维制药有限公司 用于在归因于线粒体氧化磷酸化的复合体i相关损伤的乳酸性酸中毒或药物诱导的副作用的治疗中应用的琥珀酸酯前药
ES2953522T3 (es) * 2014-04-08 2023-11-14 Abliva Ab Compuestos de succinato novedosos con permeabilidad celular
KR20160143731A (ko) 2014-04-08 2016-12-14 뉴로바이브 파마슈티컬 에이비 Atp 생산을 증가시키기 위한 숙신산 프로드러그

Similar Documents

Publication Publication Date Title
JP7229189B2 (ja) 新規な細胞透過性サクシネート化合物
CA2755918C (en) Oxadiazole derivatives
JP2017518960A (ja) Atp産生を増加するためのコハク酸のプロドラッグ
CN101596191A (zh) 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂
CN120076806A (zh) 使用slc6a19功能的螺取代的和其他哌啶抑制剂治疗pku
JP2017510603A (ja) 乳酸アシドーシス、又はミトコンドリアの酸化的リン酸化の複合体i関連障害に起因する薬剤誘発性副作用の治療における使用のための、サクシネートプロドラッグ
ES2773376T3 (es) Amidas de ácidos grasos, composiciones y procedimientos de uso
WO2017060420A1 (en) Protected fumaric acid-based metabolites for the treatment of autoimmune diseases
CN115298159A (zh) 与氧化应激相关的病症的治疗和用于其的化合物
WO2017060422A1 (en) Protected carboxylic acid-based metabolites for the treatment of mitochondrial disorders
HK1255109B (en) Novel cell-permeable succinate compounds
BR112016023086B1 (pt) Composto, composição, e, uso de um composto
HK1228251A1 (en) Novel cell-permeable succinate compounds
HK1228251B (en) Novel cell-permeable succinate compounds